April 18, 2019 According to Henry Ford, “Exercise is bunk. If you are healthy, you don’t need it: if you are sick you should not take it.” Just the opposite says Clinical Specialist Exercise Physiologist Heather Milton, MS, RCEP, CSCS at NYU Langone Medical Center Sports Performance Center. Presenting at the Lupus Lifestyle Series sponsored […] READ MORE
April 12, 2019 We are pleased to share that 12 new research grants were just awarded by the Lupus Research Program (LRP) within the Department of Defense! The $5 million allocated by Congress will continue to support promising research to help improve lupus treatment. The response from researchers to this grant opportunity was tremendous — […] READ MORE
April 11, 2019 The Lupus Research Alliance is pleased to report on an inspirational talk our fellow colleague and good friend Kathleen Arntsen, President & CEO of Lupus and Allied Diseases Association, Inc. (LADA) gave at the recent 13th International Congress on Systemic Lupus Erythematosus. Called LUPUS 2019, the meeting was an opportunity for researchers, […] READ MORE
April 11, 2019 The Lupus Research Alliance is pleased to share the results from four clinical trials presented at LUPUS 2019. These studies continue to push our way forward toward new and improved treatments to help the lupus community. There’s a Silver Lining in New Belimumab Results Jim Oates, MD, Medical University of South Carolina, […] READ MORE
April 11, 2019 The bacteria that cause urinary tract infections may trigger lupus flares, a former Alzheimer’s disease therapy has shown promising results in research models—these are just some of the findings presented by Lupus Research Alliance-funded scientists at the 13th International Congress on Systematic Lupus Erythematosus (LUPUS 2019), held in San Francisco. Here are […] READ MORE
April 10, 2019 New recommendations for treating systemic lupus erythematosus were just issued by EULAR – the European League Against Rheumatism (EULAR) and published in Annals of the Rheumatic Diseases . A group of researchers from 29 medical centers across Europe reviewed all the current literature on lupus treatment to formulate questions, elicit expert opinions […] READ MORE
April, 2019 In November, top-flight research scientists, pharmaceutical industry representatives, and advocates met in New York City to take part in the Forum for Discovery on November 28th – 30th, 2018. This annual scientific conference is orchestrated by the Lupus Research Alliance. More than 20 Lupus Research Alliance-funded investigators described their latest research in detail, […] READ MORE
April, 2019 The Lupus Research Alliance is proud to welcome renowned expert in rheumatology and immunology, Gary Koretzky, MD, PhD, as co-chair of our Scientific Advisory Board (SAB). He will co-chair the SAB with the distinguished Dr. Mary “Peggy” Crow. Dr. Crow is Physician-in-Chief and Chair of the Department of Medicine at Hospital for Special […] READ MORE
April, 2019 As our name implies, the Lupus Research Alliance aims to forge partnerships and bring other players to the table to better understand and treat lupus — and our latest venture holds the promise of a new therapy. We — and our affiliate, Lupus Therapeutics — are about to collaborate with Takeda Pharmaceutical Company […] READ MORE
April, 2019 Making new and efficacious lupus therapies available to patients has long been a major focus of the Lupus Research Alliance, and today we’ve taken an important step toward that aim. Based on a breakthrough discovery made by Betty Diamond, MD of Feinstein Institutes for Medical Research, Meggan Mackay, MD, MS, also at Feinstein, will […] READ MORE
March 28, 2019 Thank you to the Congressional Lupus Caucus Co-chairs for leading, and to all the Representatives who signed on to a letter to the House Appropriations Committee asking for increased funding to support critically important lupus research programs in FY 2020. Kudos to our advocates who urged legislators online and in person to […] READ MORE
March 27, 2019 As reported by Medical University of South Carolina, a new study published in Lupus Science & Medicine identifies a specific enzyme in the lining of blood vessels that produces nitric oxide as a potential target in treating heart disease – both in lupus and in otherwise healthy individuals. Restoring the function of […] READ MORE
